Back to search

Article

rAAV prostaglandin-based gene therapy lowers intraocular pressure and preserves optic nerve health in glaucomatous DBA/2J mice

2026-03-31

Abstract excerpt

<h4>ABSTRACT</h4> Open-angle glaucoma (OAG) affects approximately 57.5 million individuals worldwide and is characterized by the progressive loss of retinal ganglion cells (RGC) and irreversible optic nerve damage resulting from chronic ocular hypertension. Intraocular pressure (IOP) is the only major modifiable risk factor in OAG and clinical treatments necessarily aim to lower IOP in order to preserve RGCs and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d9c0e722-3cee-59e3-b7ec-62bf63eda109
DOI
10.64898/2026.03.27.714838
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
rAAV prostaglandin-based gene therapy lowers intraocular pressure and preserves optic nerve health in glaucomatous DBA/2J miceDOI 10.64898/2026.03.27.714838
Select a neighboring publication to make it the new centre.